Back to
GEODE CAPITAL MANAGEMENT, LLC
KNSA
Showing 0 of 23 quarters
Position history for
GEODE CAPITAL MANAGEMENT, LLC's holdings in KINIKSA PHARMACEUTICALS-A
As of its Q1 2024 13F, Geode Capital Management held 725,511 shares of KNSA (Kiniksa Pharmaceuticals), worth $14.3M. Geode Capital Management's 13F filings listed KNSA from Q4 2018 to Q1 2024, 22 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.